Cytometry Part A
Copyright © International Society for Advancement of Cytometry

Edited By: Attila Tárnok
Impact Factor: 3.753
ISI Journal Citation Reports © Ranking: 2010: 20/71 (BIOCHEMICAL RESEARCH METHODS); 20/71 (Biochemical Research Methods); 75/178 (Cell Biology)
Online ISSN: 1552-4930
Associated Title(s): Cytometry Part B: Clinical Cytometry
Recently Published Issues
Current Issue:February 2012
Volume 81A, Issue 2
Volume 81A, Issue 1
Volume 79A, Issue 12
Volume 79A, Issue 11
Volume 79A, Issue 10
Special Issue: In Vivo Flow Cytometry
Special Issue on In Vivo Flow Cytometry - Highlights
Guest editors Valery V. Tuchin, Attila Tárnok, and Vladimir P. Zharov provide a “horizon of opportunities” in this topical issue with a focus on in vivo flow cytometry. Applications and techniques are explored and reviewed for analysis of small multicellular organisms, cell labeling, monitoring multiple blood rheology parameters, and other recent advances. This Special Issue is now freely available online. Click here to access the summaries of each of the selected special issue articles listed below.
Negative photocoustic effect as a marker of circulating clots may prevent stroke
In vivo flow cytometry can monitor cell and nanoparticle trafficking in circulation
Photoacoustic flow cytometry tracks transport of nanoparticles in live plants in real-time
New techniques for imaging sickle cell disease
Impact Factor
1552-4930/asset/homepages/CYTO-a-IF.gif?v=1&s=d6a40f554f55a0ad1ffb726c543decd8ecb7cecd)
Call for OMIPs
Cytometry Part A is pleased to announce the acceptance of OMIPs (Optimized Multicolor Immunofluorescence Panels)
Benefits to Authors and the Research Community Include:
A mechanism for communicating and disseminating complex panels of reagents designed to interrogate phenotypic or functional aspects of cells
Acknowledgement of the effort and value the optimized panel provides with a citable publication
The OMIP can serve to dramatically shorten development efforts in labs that are initiating a new immunophenotyping study
Read the first two published OMIPs!

1552-4930/asset/olbannerleft.gif?v=1&s=cf6fcbfdc8ffa722551b71f8be0977b5b04db6ee)
1552-4930/asset/olbannerright.gif?v=1&s=6d0ba4e64946e5d9d4ebba4b8395a68bf324cd0b)
1552-4930/asset/homepages/isac-join.gif?v=1&s=2a06bc4eda1471ebe7624f4fae3cd354f49c734b)
1552-4930/asset/homepages/nfig002s.jpg?v=1&s=5d148ff2b14a62f9fbfc1d9fdfb586992f64b4b3)
1552-4930/asset/society1image.gif?v=1&s=cbad6850cca61bc0c76ce3993f22c8b15969c7a6)